Spain · Delayed Price · Currency is EUR Labiana Health Statistics
Total Valuation
Labiana Health has a market cap or net worth of EUR 52.70 million. The enterprise value is 82.49 million.
| Market Cap | 52.70M |
| Enterprise Value | 82.49M |
Important Dates
The last earnings date was Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Labiana Health has 8.30 million shares outstanding.
| Current Share Class | 8.30M |
| Shares Outstanding | 8.30M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.50% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 17.38 and the forward PE ratio is 8.15.
| PE Ratio | 17.38 |
| Forward PE | 8.15 |
| PS Ratio | 0.69 |
| PB Ratio | 11.08 |
| P/TBV Ratio | 9.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 31.01 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.11 |
| EV / Sales | 1.08 |
| EV / EBITDA | 8.54 |
| EV / EBIT | 11.37 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 7.71.
| Current Ratio | 1.39 |
| Quick Ratio | 0.84 |
| Debt / Equity | 7.71 |
| Debt / EBITDA | 3.79 |
| Debt / FCF | -13.80 |
| Interest Coverage | 1.23 |
Financial Efficiency
Return on equity (ROE) is 69.73% and return on invested capital (ROIC) is 132.31%.
| Return on Equity (ROE) | 69.73% |
| Return on Assets (ROA) | 8.28% |
| Return on Invested Capital (ROIC) | 132.31% |
| Return on Capital Employed (ROCE) | 20.80% |
| Weighted Average Cost of Capital (WACC) | 9.71% |
| Revenue Per Employee | 194,019 |
| Profits Per Employee | 6,521 |
| Employee Count | 394 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 2.82 |
Taxes
| Income Tax | -1.36M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.39% in the last 52 weeks. The beta is 0.61, so Labiana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +65.39% |
| 50-Day Moving Average | 6.71 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 5,827 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Labiana Health had revenue of EUR 76.44 million and earned 2.57 million in profits. Earnings per share was 0.37.
| Revenue | 76.44M |
| Gross Profit | 43.87M |
| Operating Income | 7.26M |
| Pretax Income | 1.20M |
| Net Income | 2.57M |
| EBITDA | 9.66M |
| EBIT | 7.26M |
| Earnings Per Share (EPS) | 0.37 |
Balance Sheet
The company has 5.91 million in cash and 36.67 million in debt, with a net cash position of -30.75 million or -3.71 per share.
| Cash & Cash Equivalents | 5.91M |
| Total Debt | 36.67M |
| Net Cash | -30.75M |
| Net Cash Per Share | -3.71 |
| Equity (Book Value) | 4.76M |
| Book Value Per Share | 0.81 |
| Working Capital | 8.87M |
Cash Flow
In the last 12 months, operating cash flow was 1.70 million and capital expenditures -4.36 million, giving a free cash flow of -2.66 million.
| Operating Cash Flow | 1.70M |
| Capital Expenditures | -4.36M |
| Depreciation & Amortization | 3.79M |
| Net Borrowing | 1.51M |
| Free Cash Flow | -2.66M |
| FCF Per Share | -0.32 |
Margins
Gross margin is 57.39%, with operating and profit margins of 9.49% and 3.36%.
| Gross Margin | 57.39% |
| Operating Margin | 9.49% |
| Pretax Margin | 1.57% |
| Profit Margin | 3.36% |
| EBITDA Margin | 12.64% |
| EBIT Margin | 9.49% |
| FCF Margin | n/a |
Dividends & Yields
Labiana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.88% |
| FCF Yield | -5.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Labiana Health has an Altman Z-Score of 2.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.41 |
| Piotroski F-Score | 4 |